Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

United Therapeutics Corp (NASDAQ:UTHR)

126.56
Delayed Data
As of Feb 12
 +4.95 / +4.07%
Today’s Change
113.20
Today|||52-Week Range
190.29
-19.19%
Year-to-Date

Today’s Trading

Previous close121.61
Today’s open124.18
Day’s range121.71 - 128.20
Volume731,580
Average volume (3 months)718,087
Market cap$5.8B
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+91.46%
Earnings growth (this year)+109.60%
Earnings growth (next 5 years)+15.15%
Revenue growth (last year)+15.36%
P/E ratio10.0
Price/Sales5.44
Price/Book4.80

Competitors

 Today’s
change
Today’s
% change
TAROTaro Pharmaceutical ...+1.87+1.42%
IDXXIDEXX Laboratories I...+0.58+0.86%
MDVNMedivation Inc+1.86+6.51%
ALKSAlkermes Plc+1.26+4.04%
Data as of 4:02pm ET, 02/12/2016

Financials

Next reporting dateFebruary 23, 2016
EPS forecast (this quarter)$2.59
Annual revenue (last year)$1.3B
Annual profit (last year)$340.1M
Net profit margin26.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Co-Chief Executive Officer
Martine A. Rothblatt
President, Co-Chief Executive Officer &
Director
Roger A. Jeffs
Corporate headquarters
Silver Spring, Maryland

Forecasts

Partner Offers